Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1979 Jul;72(7):513–519. doi: 10.1177/014107687907200710

Antiplatelet agents: a review.

M L Gantmacher
PMCID: PMC1436964  PMID: 399644

Full text

PDF
513

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acheson J., Danta G., Hutchinson E. C. Controlled trial of dipyridamole in cerebral vascular disease. Br Med J. 1969 Mar 8;1(5644):614–615. doi: 10.1136/bmj.1.5644.614. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Acheson J., Hutchinson E. C. Controlled trial of clofibrate in cerebral vascular disease. Atherosclerosis. 1972 Mar-Apr;15(2):177–183. doi: 10.1016/0021-9150(72)90067-6. [DOI] [PubMed] [Google Scholar]
  3. Arrants J. E., Hairston P. Use of Persantine in preventing thromboembolism following valve replacement. Am Surg. 1972 Aug;38(8):432–435. [PubMed] [Google Scholar]
  4. Dyken M. L., Kolar O. J., Jones F. H. Differences in the occurrence of carotid transient ischemic attacks associated with antiplatelet aggregation therapy. Stroke. 1973 Sep-Oct;4(5):732–736. doi: 10.1161/01.str.4.5.732. [DOI] [PubMed] [Google Scholar]
  5. Elwood P. C., Cochrane A. L., Burr M. L., Sweetnam P. M., Williams G., Welsby E., Hughes S. J., Renton R. A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction. Br Med J. 1974 Mar 9;1(5905):436–440. doi: 10.1136/bmj.1.5905.436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Evans G. Effect of drugs that suppress platelet surface interaction on incidence of amaurosis fugax and transient cerebral ishcemia. Surg Forum. 1972;23(0):239–241. [PubMed] [Google Scholar]
  7. Fields W. S., Lemak N. A., Frankowski R. F., Hardy R. J. Controlled trial of aspirin in cerebral ischemia. Stroke. 1977 May-Jun;8(3):301–314. doi: 10.1161/01.str.8.3.301. [DOI] [PubMed] [Google Scholar]
  8. Gent A. E., Brook C. G., Foley T. H., Miller T. N. Dipyridamole: a controlled trial of its effect in acute myocardial infarction. Br Med J. 1968 Nov 9;4(5627):366–368. doi: 10.1136/bmj.4.5627.366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Harris W. H., Salzman E. W., Athanasoulis C. A., Waltman A. C., DeSanctis R. W. Aspirin prophylaxis of venous thromboembolism after total hip replacement. N Engl J Med. 1977 Dec 8;297(23):1246–1249. doi: 10.1056/NEJM197712082972302. [DOI] [PubMed] [Google Scholar]
  10. Harrison M. J., Marshall J., Meadows J. C., Russell R. W. Effect of aspirin in amaurosis fugax. Lancet. 1971 Oct 2;2(7727):743–744. doi: 10.1016/s0140-6736(71)92108-8. [DOI] [PubMed] [Google Scholar]
  11. Kaegi A., Pineo G. F., Shimizu A., Trivedi H., Hirsh J., Gent M. The role of sulfinpyrazone in the prevention of arterio-venous shunt thrombosis. Circulation. 1975 Sep;52(3):497–499. doi: 10.1161/01.cir.52.3.497. [DOI] [PubMed] [Google Scholar]
  12. Steele P. P., Weily H. S., Davies H., Genton E. Platelet survival in patients with rheumatic heart disease. N Engl J Med. 1974 Mar 7;290(10):537–539. doi: 10.1056/NEJM197403072901003. [DOI] [PubMed] [Google Scholar]
  13. Steele P. P., Weily H. S., Genton E. Platelet survival and adhesiveness in recurrent venous thrombosis. N Engl J Med. 1973 May 31;288(22):1148–1152. doi: 10.1056/NEJM197305312882203. [DOI] [PubMed] [Google Scholar]
  14. Steele P., Battock D., Genton E. Effects of clofibrate and sulfinpyrazone on platelet survival time in coronary artery disease. Circulation. 1975 Sep;52(3):473–476. doi: 10.1161/01.cir.52.3.473. [DOI] [PubMed] [Google Scholar]
  15. Steele P., Carroll J., Overfield D., Genton E. Effect of sulfinpyrazone on platelet survival time in patients with transient cerebral ischemic attacks. Stroke. 1977 May-Jun;8(3):396–398. doi: 10.1161/01.str.8.3.396. [DOI] [PubMed] [Google Scholar]
  16. Steele P., Ellis J. H., Jr, Weily H. S., Genton E. Platelet survival time in patients with hypoxemia and pulmonary hypertension. Circulation. 1977 Apr;55(4):660–661. doi: 10.1161/01.cir.55.4.660. [DOI] [PubMed] [Google Scholar]
  17. Steele P., Weily H., Davies H., Ppppas G., Genton E. Platelet survival time following aortic valve replacement. Circulation. 1975 Feb;51(2):358–362. doi: 10.1161/01.cir.51.2.358. [DOI] [PubMed] [Google Scholar]
  18. Sullivan J. M., Harken D. E., Gorlin R. Pharmacologic control of thromboembolic complications of cardiac-valve replacement. N Engl J Med. 1971 Jun 24;284(25):1391–1394. doi: 10.1056/NEJM197106242842501. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES